Equities

SANUWAVE Health Inc

SNWV:QBB

SANUWAVE Health Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.015
  • Today's Change0.001 / 7.14%
  • Shares traded873.25k
  • 1 Year change-16.20%
  • Beta1.0776
Data delayed at least 15 minutes, as of Jul 26 2024 20:20 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. The Company is a provider of Food and Drug Administration (FDA)-approved wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The Company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and others. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing from within. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression (PACE) technology to converge at precise selected targets to produce an extremely short duration compression burst.

  • Revenue in USD (TTM)22.41m
  • Net income in USD-17.26m
  • Incorporated2004
  • Employees31.00
  • Location
    SANUWAVE Health Inc3360 Martin Farm Rd, Suite 100SUWANEE 30024United StatesUSA
  • Phone+1 (770) 419-7525
  • Fax+1 (770) 419-8634
  • Websitehttps://sanuwave.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PetVivo Holdings Inc968.71k-10.96m12.94m20.00--16.16--13.36-0.8091-0.80910.06940.04020.34880.602818.3948,435.50-394.49-230.77-815.08-467.9976.3466.21-1,130.92-1,501.440.4613-1,644.170.1993--5.62---25.67--23.91--
Nexalin Technology Inc158.86k-4.94m13.13m6.00--3.96--82.63-0.6676-0.66760.02150.31290.03630.177844.0126,476.67-112.76---139.94--82.54---3,110.58--4.75--0.00---91.62---173.80------
Vapotherm Inc70.07m-54.94m13.24m182.00------0.1889-8.62-8.6211.00-11.020.81221.467.53385,011.00-63.68-49.73-587.27-62.5445.2843.56-78.40-78.990.1259-1.272.59--2.8010.1448.62---10.38--
QT Imaging Holdings Inc0.00-4.02m13.72m----0.6312-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
STRATA Skin Sciences Inc32.55m-11.36m13.93m99.00--1.24--0.4281-3.25-3.259.312.690.733.678.60328,737.40-25.49-11.48-35.77-16.5552.7161.28-34.91-17.700.8376-3.900.6151---7.752.24-95.17--23.29--
REMSleep Holdings Inc175.95k-1.80m14.46m6.00--21.36--82.17-0.0012-0.00120.00010.00050.08481.6911.20---86.95-152.40-108.40-317.98-411.78---1,025.38-2,317.521.63-18.540.0673---36.48--12.13--28.26--
Dalrada Financial Corporation32.16m-21.34m15.82m0.00--1.79--0.492-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Biotricity Inc12.06m-14.93m16.11m55.00------1.34-1.66-1.661.34-3.151.941.768.96219,333.60-226.36-269.25----69.2758.93-116.84-258.940.1142-0.711----25.1597.8223.57------
SANUWAVE Health Inc22.41m-17.26m17.72m31.00------0.7908-0.0267-0.02670.0238-0.04171.103.607.50722,838.70-84.54-136.54----71.6369.13-77.00-189.600.11930.0192----21.8461.61-150.72------
Bionoid Pharma Inc0.001.35m18.36m13.000.2998--13.57--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
Orgenesis Inc529.00k-45.66m18.59m146.00------35.15-1.53-1.530.0174-0.80720.010149.690.0493,623.29-98.12---338.48---660.87---9,744.05--0.0662-12.23-----98.53-50.94-271.82---17.71--
Scientific Industries Inc10.79m-8.77m19.80m63.00--1.57--1.84-1.13-1.131.341.200.67621.199.31171,263.50-54.96---63.27--44.53---81.28--3.19--0.00--------------
Inspira Technologies Oxy BHN Ltd0.00-11.29m20.01m37.00--2.97-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
Golden Valley Development Inc0.00-92.53k20.52m0.00---------11.17-11.170.00-0.02110.00-------7,710.83-------------3,073.27---3.96--------45.48------
Neuraxis Inc2.30m-14.39m21.21m19.00------9.21-3.71-3.710.4945-0.48291.825.8110.14121,135.80-1,154.78------87.72---633.21--0.1016-13.46-----8.37---163.78------
Neuroone Medical Technologies Corp3.77m-12.80m22.12m16.00--5.49--5.87-0.5877-0.58770.16790.14640.5982.129.79235,460.60-203.24-172.88-269.30-274.7430.12---339.86-674.972.21--0.00--62.66---18.60------
Data as of Jul 26 2024. Currency figures normalised to SANUWAVE Health Inc's reporting currency: US Dollar USD

Institutional shareholders

42.33%Per cent of shares held by top holders
HolderShares% Held
Manchester Management Co. LLCas of 03 Jul 2024369.13m32.21%
Opaleye Management, Inc.as of 03 Jul 2024115.49m10.08%
Strategic Investment Solutions, Inc. (Illinois)as of 31 Dec 2023500.00k0.04%
Data from 31 Dec 2023 - 03 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.